Live Chat ×
Skip to main content

Clinical Microbiology Virtual Journal Club

Join us in discussing recent journal articles in clinical microbiology. Each month a group of presenters will discuss one or two articles in-depth. Journal clubs are held every second Tuesday at 2pm Eastern.

This activity is free to ASM members.

New Antibiotics: Cefiderocol and Lefamulin
March 10 Session
Register Now!

Articles for Discussion
Michael Jacobs et al., ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum B-Lactamases and Carbapenemases, Antimicrobial Agents and Chemotherapy, Volume 63, Issue 1, Jan 2019. DOI: 10.1128/AAC.01801-18.

Susanne Paukner et al., Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program, Antimicrobial Agents and Chemotherapy, Volume 63, Issue 4, Apr 2019. DOI: 10.1128/AAC.02161-18.

Arryn Craney, PhD, D(ABMM), Weill Cornell Medicine
Nicholas Moore, PhD, MLS(ASCP)cm, Rush University

Matthew Pettengill, PhD, D(ABMM), Thomas Jefferson University

Discussion Panel
Joseph Blondeau, PhD, FCCP, Royal University Hospital, Saskatchewan
James Kirby, MD, D(ABMM), Beth Israel Deaconess, Harvard Medical School